Literature DB >> 31515181

Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study.

Noa Krawczyk1, Matthew Eisenberg2, Kristin E Schneider3, Tom M Richards4, B Casey Lyons5, Kate Jackson5, Lindsey Ferris6, Jonathan P Weiner7, Brendan Saloner8.   

Abstract

STUDY
OBJECTIVE: Persons with substance use disorders frequently utilize emergency department (ED) services, creating an opportunity for intervention and referral to addiction treatment and harm-reduction services. However, EDs may not have the appropriate tools to distinguish which patients are at greatest risk for negative outcomes. We link hospital ED and medical examiner mortality databases in one state to identify individual-level risk factors associated with overdose death among ED patients with substance-related encounters.
METHODS: This retrospective cohort study linked Maryland statewide ED hospital claims records for adults with nonfatal overdose or substance use disorder encounters in 2014 to 2015 with medical examiner mortality records in 2015 to 2016. Logistic regression was used to identify factors in hospital records associated with risk of opioid overdose death. Predicted probabilities for overdose death were calculated for hypothetical patients with different combinations of overdose and substance use diagnostic histories.
RESULTS: A total of 139,252 patients had substance-related ED encounters in 2014 to 2015. Of these patients, 963 later experienced an opioid overdose death, indicating a case fatality rate of 69.2 per 10,000 patients, 6 times higher than that of patients who used the ED for any cause. Factors most strongly associated with death included having both an opioid and another substance use disorder (adjusted odds ratio 2.88; 95% confidence interval 2.04 to 4.07), having greater than or equal to 3 previous nonfatal overdoses (adjusted odds ratio 2.89; 95% confidence interval 1.54 to 5.43), and having a previous nonfatal overdose involving heroin (adjusted odds ratio 2.24; 95% confidence interval 1.64 to 3.05).
CONCLUSION: These results highlight important differences in overdose risk among patients receiving care in EDs for substance-related conditions. The findings demonstrate the potential utility of incorporating routine data from patient records to assess risk of future negative outcomes and identify primary targets for initiation and linkage to lifesaving care.
Copyright © 2019 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31515181      PMCID: PMC6928412          DOI: 10.1016/j.annemergmed.2019.07.014

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  43 in total

1.  Proposed ICD-10-CM Surveillance Case Definitions for Injury Hospitalizations and Emergency Department Visits.

Authors:  Holly B Hedegaard; Renee L Johnson; Michael F Ballesteros
Journal:  Natl Health Stat Report       Date:  2017-01

2.  Opportunities for Prevention and Intervention of Opioid Overdose in the Emergency Department.

Authors:  Debra E Houry; Tamara M Haegerich; Alana Vivolo-Kantor
Journal:  Ann Emerg Med       Date:  2018-03-06       Impact factor: 5.721

3.  Using electronic health records data to identify patients with chronic pain in a primary care setting.

Authors:  Terrence Y Tian; Ianita Zlateva; Daren R Anderson
Journal:  J Am Med Inform Assoc       Date:  2013-07-31       Impact factor: 4.497

4.  Emergency Department Visits in a Cohort of Persons with Substance Use: Incorporating the Role of Social Networks.

Authors:  Paul Sacamano; Noa Krawczyk; Carl Latkin
Journal:  Subst Use Misuse       Date:  2018-04-19       Impact factor: 2.164

5.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

6.  Opioid education and nasal naloxone rescue kits in the emergency department.

Authors:  Kristin Dwyer; Alexander Y Walley; Breanne K Langlois; Patricia M Mitchell; Kerrie P Nelson; John Cromwell; Edward Bernstein
Journal:  West J Emerg Med       Date:  2015-04-01

7.  Feasibility of a computer-assisted alcohol SBIRT program in an urban emergency department: patient and research staff perspectives.

Authors:  Mary K Murphy; Polly E Bijur; David Rosenbloom; Steven L Bernstein; E John Gallagher
Journal:  Addict Sci Clin Pract       Date:  2013-01-16

8.  Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse.

Authors:  Astha Singhal; Yu-Yu Tien; Renee Y Hsia
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

9.  Patterns of health care utilization and cost before and after opioid overdose: findings from 10-year longitudinal health plan claims data.

Authors:  Daniel D Maeng; John J Han; Michael H Fitzpatrick; Joseph A Boscarino
Journal:  Subst Abuse Rehabil       Date:  2017-08-16

Review 10.  Emergency department screening and interventions for substance use disorders.

Authors:  Kathryn Hawk; Gail D'Onofrio
Journal:  Addict Sci Clin Pract       Date:  2018-08-06
View more
  17 in total

Review 1.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

2.  Descriptive Analysis of Inpatient and Outpatient Cohorts Seeking Treatment After Prescription Opioid Misuse and Medical Toxicology Evaluation.

Authors:  Shawn M Varney; Timothy J Wiegand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2021-08-16

3.  Fatal overdose: Predicting to prevent.

Authors:  Annick Borquez; Natasha K Martin
Journal:  Int J Drug Policy       Date:  2022-05-09

4.  Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.

Authors:  Jingchuan Guo; Wei-Hsuan Lo-Ciganic; Qingnan Yang; James L Huang; Jeremy C Weiss; Gerald Cochran; Daniel C Malone; Courtney C Kuza; Adam J Gordon; Julie M Donohue; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2021-01-22       Impact factor: 5.128

5.  Non-fatal stimulant overdose among homeless and unstably housed women in San Francisco, California.

Authors:  Thibaut Davy-Mendez; Eric Vittinghoff; Samantha E Dilworth; Leslie W Suen; Carl Braun; Phillip O Coffin; Derek D Satre; Elise D Riley
Journal:  Drug Alcohol Depend       Date:  2021-09-22       Impact factor: 4.492

6.  Addressing multiple overdoses: Opportunities for prevention and innovation.

Authors:  Sarah M Bagley; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2021-07-28

Review 7.  Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data.

Authors:  Iraklis Erik Tseregounis; Stephen G Henry
Journal:  Transl Res       Date:  2021-03-21       Impact factor: 10.171

8.  Identifying pathways to recent non-fatal overdose among people who use opioids non-medically: How do psychological pain and unmet mental health need contribute to overdose risk?

Authors:  Catherine Tomko; Kristin E Schneider; Saba Rouhani; Glenna J Urquhart; Ju Nyeong Park; Miles Morris; Susan G Sherman
Journal:  Addict Behav       Date:  2021-12-20       Impact factor: 4.591

9.  Hospital Care for Opioid use in Illinois, 2016-2019.

Authors:  Joe Feinglass; Jessica Ann Wang; Jiancheng Ye; Robert Tessier; Howard Kim
Journal:  J Behav Health Serv Res       Date:  2021-01-27       Impact factor: 1.505

10.  Interobserver agreement between emergency clinicians and nurses for Clinical Opiate Withdrawal Scale.

Authors:  Christian A Tomaszewski; Faith Quenzer; Bryan Corbett; Andrew Lafree; Daniel Lasoff; Jorge Romo; Leslie Mukau
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.